Product Information

CICLOPIROX 0.77% CREAM is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $0.1045 per GM under NDC 45802013818. Its NADAC has been published 665 times since Nov 28, 2013.

FDA first approved this application on Mar 3, 2006. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the Ciclopirox olamine market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

CICLOPIROX 0.77% CREAM

Ciclopirox olamine
$0.1045per GM
High Outlier

Strength

7.7 mg/g

NDC

45802013818

Classification

Generic

Dosage Form

CREAM

Route

TOPICAL

Effective Date

8/19/2026

Active Ingredients

CICLOPIROX OLAMINE

Approval Type

Generic (ANDA)

FDA Application

ANDA077364

FDA Approved

3/3/2006

TE Code

AB

On Market Since

7/19/2006

Pharmacological Classes

Decreased DNA Replication
Decreased Protein Synthesis
Decreased RNA Replication
Protein Synthesis Inhibitors

Price Statistics

The NADAC for CICLOPIROX 0.77% CREAM has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 48.8%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1045 per GM
All-time high$0.2801 (Jan 15, 2014)
All-time low$0.0932 (Nov 20, 2024)
52-week high$0.1088
52-week low$0.1019
Median price$0.1282
Average price$0.1478
Largest weekly change+45.2% (Apr 22, 2015)
Weeks tracked665
Tracking sinceNov 28, 2013

Price History

1W

+2.4%

1M

+2.4%

3M

-2.2%

6M

+0.3%

1Y

-1.7%

3Y

-9.0%

5Y

-17.1%

All

-48.8%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of CICLOPIROX 0.77% CREAM?

The current National Average Drug Acquisition Cost (NADAC) for CICLOPIROX 0.77% CREAM, manufactured by Padagis Israel Pharmaceuticals Ltd, is $0.1045 per GM (NDC 45802013818), effective Aug 19, 2026.

How has the price of CICLOPIROX 0.77% CREAM changed over time?

Over the history we have for it, the NADAC for CICLOPIROX 0.77% CREAM has declined 48.8%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for CICLOPIROX 0.77% CREAM?

Since Nov 28, 2013, the NADAC for CICLOPIROX 0.77% CREAM has ranged from a low of $0.0932 (Nov 20, 2024) to a high of $0.2801 (Jan 15, 2014), with a median of $0.1282 per GM.

Are there cheaper alternatives to CICLOPIROX 0.77% CREAM?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as CICLOPIROX 0.77% CREAM in a comparable dosage form, but none are currently priced below it.

Who manufactures CICLOPIROX 0.77% CREAM?

CICLOPIROX 0.77% CREAM (NDC 45802013818) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.